PL EN


Preferencje help
Widoczny [Schowaj] Abstrakt
Liczba wyników
Tytuł artykułu

Simultaneous estimation of atorvastatin calcium and aspirin in combined dosage form by liquid chromatographic method

Identyfikatory
Warianty tytułu
Języki publikacji
EN
Abstrakty
EN
An isocratic reversed-phase liquid chromatograpic assay method was developed for the quantitative determination of atorvastatin and aspirin (ASP) in combined dosage form. A Phenomenex Gemini C-18, 5-μm column with mobile phase containing 0.02 M potassium dihydrogen phosphate-acetonitrile-methanol (30:30:40, v/v/v) adjusted to pH 3 using o-phosphoric acid was used. The flow rate was 1.0 mL min -1 and effluents were monitored at 240 nm. The retention times (RTs) of atorvastatin calcium (ATV) and ASP were 10.5 and 3.8 min, respectively. ATV and ASP stock solutions were subjected to acid and alkali hydrolysis, chemical oxidation, and dry heat degradation. The degraded product peaks were well resolved from the pure drug peak with significant difference in their RT values. Stressed samples were assayed using developed LC method. The proposed method was validated with respect to linearity, accuracy, precision, and robustness. The method was successfully applied to the estimation of ATV and ASP in combined capsule dosage forms.
Rocznik
Strony
51--64
Opis fizyczny
Bibliogr. 19 poz., rys., tab.
Twórcy
autor
  • Indukaka Ipcowala College of Pharmacy P.B. No. 53 New Vallabh Vidyanagar 388 121 Dist. Anand Gujarat India
autor
  • Indukaka Ipcowala College of Pharmacy P.B. No. 53 New Vallabh Vidyanagar 388 121 Dist. Anand Gujarat India
  • Indukaka Ipcowala College of Pharmacy P.B. No. 53 New Vallabh Vidyanagar 388 121 Dist. Anand Gujarat India
Bibliografia
  • [1] S. Budavari, The Merck Index, 12th edn, Merck & Co. Inc., Whitehouse Station, NJ, 1996, p. 897
  • [2] A.E. Gennaro, Remington’s — The Science and Practice of Pharmacy, 20th edn, Mack Publishing Co, Easton, PA, 2000, Vol. II, p. 1294
  • [3] K. Nakamuara, H. Masuda, H. Kariyazono, J. Arima, Y. Iguro, K. Yamada, and R. Sakata, Cytokine, 36, 201–210 (2006)
  • [4] V.G. Athyros, D.P. Mikahilidis, A.A. Papageorgiou, V.I. Bouloukos, A.N. Pehlivanidis, A.N. Symeonidis, A.I. Kakafika, S.S. Daskalogoulou, and M. Elisaf, Platelets, 16, 65–71 (2005)
  • [5] N. Erk, Anal. Lett., 36, 2699–2711 (2003)
  • [6] H.R. Shen, D. Liz, and M.K. Zhong, Pharmazie, 61, 18–20 (2006)
  • [7] J.C. Verd, C. Peris, M. Alergret, C. Diaz, Z.G. Hernandez, and R.M. Sanchez, Brit. J. Pharmacol., 127, 1479–1485 (1999)
  • [8] B.E. Bleske, R.A. Willis, M. Anthony, N. Casselberry, M. Datwani, and V.E. Uhley, Amer. Heart J., 142, 262 (2001)
  • [9] T.G. Altuntas and N. Erk, J. Liq. Chromatogr. Relat. Technol., 27, 83–93 (2004)
  • [10] S. Erturk, E.S. Aktas, L. Ersoy, and S.J. Ficicioglu, Pharm. Biomed. Anal., 33, 1017–1023 (2003)
  • [11] J.M. McKenney, L.S. McCormick, S. Weiss, M. Koren, S. Kafonek, and D.M. Blanck, Amer. J. Med., 104, 137–143 (1998)
  • [12] X.S. Miao and C.D. Metcalfe, J. Chromatogr. A, 998, 133–141 (2003)
  • [13] M. Jemal, Z. Ouyang, B.C. Chen, and D. Teitz, Rapid Commun. Mass Spectrom., 13, 1003–1015 (1999)
  • [14] W.W. Bullen, R.A. Miller, and R.N. Hayes, J. Amer. Soc. Mass Spectrom., 10, 55–66 (1999)
  • [15] S.S. Yadav, D.V. Mhaske, A.B. Kakad, B.D. Patil, S.S. Kadam, and S.R. Dhaneshwar, Indian J. Pharm. Sci., 67, 182–88 (2005)
  • [16] The British Pharmacopoeia, Vol. I, Her Majesty’s Stationery Office, Department of Health, London, 2007, pp. 184–185
  • [17] The United States Pharmacopoeia, Vol. I, United States Pharmacopoeial Convention Inc., Rockville, MD, 2004, pp. 171–74
  • [18] K. Manoj, P. Shanmugapandiyan, and S. Anbazhagan, Indian Drugs, 41, 284–289 (2004)
  • [19] Validation of Analytical Procedures: Methodology (Q2R1), International Conference on Harmonization (ICH), Food and Drug Administration, Washington, DC, 1996 & 2005
Typ dokumentu
Bibliografia
Identyfikator YADDA
bwmeta1.element.baztech-b72f9ff7-995d-49bd-a82b-96ef0407934f
JavaScript jest wyłączony w Twojej przeglądarce internetowej. Włącz go, a następnie odśwież stronę, aby móc w pełni z niej korzystać.